Ironwood

Ironwood, AbbVie add 'bloating' and 'discomfort' to Linzess label to reach more IBS-C patients
Ironwood, AbbVie add 'bloating' and 'discomfort' to Linzess label to reach more IBS-C patients
Fierce Pharma
Ironwood
AbbVie
Linzess
IBS-C
FDA
Flag link:
Linzess Receives Additional Indication in Japan for Chronic Constipation
Linzess Receives Additional Indication in Japan for Chronic Constipation
CP Wire
Linzess
Astellas
Ironwood
chronic constipation
Flag link:
Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster
Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster
Endpoints
AstraZeneca
gout
lesinurad
Ironwood
Flag link:
Under pressure, Peter Hecht splits Ironwood into two biotechs, spinning out an R&D operation
Under pressure, Peter Hecht splits Ironwood into two biotechs, spinning out an R&D operation
Endpoints
Ironwood
Peter Hecht
reorganization
Flag link:
Ironwood looks to boost gout franchise as FDA delivers OK for Duzallo
Ironwood looks to boost gout franchise as FDA delivers OK for Duzallo
Endpoints
Ironwood
gout
FDA
Duzallo
Flag link:
Ironwood claims a blockbuster success for its heartburn drug, but questions linger
Ironwood claims a blockbuster success for its heartburn drug, but questions linger
Endpoints
Ironwood
GERD
IW-3718
Flag link:
3 Plausible Buyout Scenarios Within Biotech
3 Plausible Buyout Scenarios Within Biotech
Seeking Alpha
biotech
Acadia
AstraZeneca
Allergan
Biogen
Teva Pharmaceutical
Biomarin
Incyte
Ironwood
Medivation
Pfizer
Relypsa
Synergy Pharmaceuticals
M&A
Flag link:
3 Big Battles Brewing in Biotech
3 Big Battles Brewing in Biotech
Motley Fool
AstraZeneca
ZS-9
Relypsa
Veltassa
Synergy Pharmaceuticals
plecanatide
Linzess
Ironwood
Allergan
Incyte
Eli Lilly
baricitinib
AbbVie
Humira
Flag link:
Ironwood steps up to challenge Valeant with Allergan's IBS med Viberzi
Ironwood steps up to challenge Valeant with Allergan's IBS med Viberzi
Fierce Pharma Marketing
Valeant Pharmaceuticals
Ironwood
Allergan
IBS
Viberzi
Flag link:
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Seeking Alpha
Synergy Pharmaceuticals
IBS-C
plecanatide
Linzess
Ironwood
Flag link:
AstraZeneca, Ironwood to seek Chinese approval for linaclotide following positive results in late-stage IBS-C trial
AstraZeneca, Ironwood to seek Chinese approval for linaclotide following positive results in late-stage IBS-C trial
First Word Pharma
AstraZeneca
Ironwood
China
linaclotide
IBS-C
Flag link:
Next DTC push for Linzess: Spotlight patients, with big salesforce backup
Next DTC push for Linzess: Spotlight patients, with big salesforce backup
Fierce Pharma Marketing
Actavis
Ironwood
DTC
Linzess
IBS-C
Flag link:
Key Pharmaceutical Stocks Ready to Deliver Earnings Beats
Key Pharmaceutical Stocks Ready to Deliver Earnings Beats
Yahoo/Zacks.com
earnings
Forest Labs
JNJ
Ironwood
Flag link:
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
TearLab
Array Biopharma
Furiex Pharmaceuticals
InterMune
Prosensa
Boston Scientific
Orexigen
Momenta
Ironwood
INSYS Therapeutics
Sequenom
OncoMed
Abraxis
Sarepta
Epizyme
Tesaro
Synta Pharmaceuticals
Bluebird Bio
Exelixis
Lexicon Pharmaceuticals
Intercept Pharma
GTx
Flag link:
The Compelling Science Behind Synergy
The Compelling Science Behind Synergy
Seeking Alpha
Synergy Pharmaceuticals
plecanatide
Ironwood
Linzess
Flag link:
Ironwood's Bowel Drug Sales Disappoint
Ironwood's Bowel Drug Sales Disappoint
TheStreet.com
Ironwood
Linzess
Forest Labs
irritable bowel syndrome
IBS
Flag link:
Synergy Pharmaceutical Could Almost Double In Value With Plecanatide
Synergy Pharmaceutical Could Almost Double In Value With Plecanatide
Seeking Alpha
plecanatide
Synergy Pharmaceuticals
Ironwood
Flag link:
Ironwood Implies Upside For Synergy; Lessons Learned From Dendreon
Ironwood Implies Upside For Synergy; Lessons Learned From Dendreon
Seeking Alpha
Ironwood
Dendreon
Synergy Pharmaceuticals
Forest Labs
Novartis
IBS-C
linaclotide
Flag link:
Patent Licensure Positive, Removes Barrier To Potential SGYP Pharma Partnership
Patent Licensure Positive, Removes Barrier To Potential SGYP Pharma Partnership
Yahoo/Reuters
patents
Synergy Pharmaceuticals
Ironwood
plecanatide
Flag link:
Synergy Pharmaceuticals: Positioning For Pipeline Payoff
Synergy Pharmaceuticals: Positioning For Pipeline Payoff
Seeking Alpha
Synergy Pharmaceuticals
plecanatide
chronic idiopathic constipation
Ironwood
Flag link:

Pages